Dáil Éireann Debate, Tuesday - 7 July 2026
834. Deputy Naoise Ó Muirí asked the Minister for Health the review she intends to take of Ireland's system for approving access and funding for new drugs and medical treatments; and if she will make a statement on the matter. [51585/26]
View answerThe State has successfully negotiated new Framework Agreements on the Supply and Pricing of Medicines with Medicines for Ireland (MFI) and the Irish Pharmaceutical Healthcare Association (IPHA).
These Agreements provide commitments and a structured process towards achieving a 180-day timeline, for completing health technology assessments (HTA) and reimbursement decisions by Q1 2029.
This structured process will be implemented over the lifetime of the Agreements and will involve, starting this year, a strategic end-to-end review of the pricing and reimbursement system its functioning. Along with other measures outlined in the Agreements, implementation of recommendations arising from the end-to-end review will enable faster access to medicines for patients in Ireland.
